Who are the latest Venture Kick winners?
12.05.2015
"Why would someone buy this?" is a question that can stump startups as they try to explain their value proposition. Fortunately for four startups pitching in the first round at venture kick session, the answers were both compelling and realistic.
 The VIBWIFE team
|
 |
 The team from Axiamo
|
|
 Tomas de Wouters from PharmaBiome
|
|
 Alberto Hernando and Miroslav Sulc from SThAR
|
|
The rate of unnecessary cesarean sections increases worldwide every year. This leads to high health and economical costs. The innovative device from VIBWIFE would drastically reduce the c-section rate by helping to reposition the baby to the ideal birth position. Resulting in a reduction of the birth duration which will allow the hospital to have higher capacities. In short: quicker births are more secure births.
Axiamo is providing the motion sensor that lets you focus on your application and gives you the objective feedback to improve the sport training and performance. The sensor is capable to process complex motion analysis algorithms. It enables not only to analyse the sport performance, it is even possible to get instant feedback.
PharmaBiome will develop an innovative technology platform to formulate safe, efficient and scalable pharma-level fecal microbiota transplant products. Fecal microbiota transplant is a novel, lifesaving therapy that has no approved pharmacological solution yet. Our technology will address this need and extend its use from last resort treatment of infections to the treatment and prevention of multiple other microbiota related diseases.
SThAR develops predictive software based on the emergent science of sociothermodynamics. Their models describe and predict social trends to optimize the success of marketing campaigns (for promoting products, brands, or electoral information), and forecast consumption patterns and evolution of sales for designing smart geomarketing strategies.
Axiamo is providing the motion sensor that lets you focus on your application and gives you the objective feedback to improve the sport training and performance. The sensor is capable to process complex motion analysis algorithms. It enables not only to analyse the sport performance, it is even possible to get instant feedback.
PharmaBiome will develop an innovative technology platform to formulate safe, efficient and scalable pharma-level fecal microbiota transplant products. Fecal microbiota transplant is a novel, lifesaving therapy that has no approved pharmacological solution yet. Our technology will address this need and extend its use from last resort treatment of infections to the treatment and prevention of multiple other microbiota related diseases.
SThAR develops predictive software based on the emergent science of sociothermodynamics. Their models describe and predict social trends to optimize the success of marketing campaigns (for promoting products, brands, or electoral information), and forecast consumption patterns and evolution of sales for designing smart geomarketing strategies.